Trend Results : DNA-based Zika


Blog Post Results (1-9 of 9)

FILTER RESULTS

DNA-based Zika vaccine is safe and effective at inducing immune response

PHILADELPHIA -- (Oct. 4, 2017) -- A new generation DNA-based Zika vaccine demonstrated both safety and ability to elicit an immune response against Zika in humans in a phase 1 clinical trial conducted through a partnership among theShow More Summary

Synthetic DNA-based Zika Vaccine Candidate Found to be Safe and Effective at Inducing Immune Response

A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman School of Medicine at the University ofShow More Summary

Zika vaccine shows promise in early human trial

2 months agoHealth : Reuters: Health

CHICAGO (Reuters) - A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.

DNA-based Zika vaccine candidate found safe and effective at inducing immune response

(University of Pennsylvania School of Medicine) A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans, according to new research from the Perelman...Show More Summary

Synthetic DNA-Based Zika Vaccine Protects Against Damage to Testes in Preclinical Models

While the Zika virus is primarily transmitted by mosquitoes, research has shown that the disease can affect semen and sperm and can therefore be spread through sexual intercourse.

University of Miami to begin phase 2 Zika vaccine trial

(University of Miami) The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine. Show More Summary

DNA-based Zika vaccine showed protection from infection, brain damage and death

A new vaccination has generated a robust and protective antigen-specific antibody and T cell immune responses in preclinical animal models, report scientists.

DNA-based Zika vaccine showed protection from infection, brain damage and death

(The Wistar Institute) In this preclinical study, 100 percent of the animal models were protected from Zika after vaccination followed by a challenge with the Zika virus. In addition, they were protected from degeneration in the cerebral cortex and hippocampal areas of the brain, while the other cohort showed degeneration of the brain after Zika infection.

Three vaccine approaches protect monkeys against Zika infection

WHAT: Three different investigational Zika virus vaccine platforms--an inactivated virus vaccine, a DNA-based vaccine, and an adenovirus vector-based vaccine--protected against infection, induced immune responses, and produced no adverse...Show More Summary

Copyright © 2015 Regator, LLC